Literature DB >> 12086262

Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis.

J Charles Jennette1.   

Abstract

The different pathologic features of different types of necrotizing vasculitis indicate that there are different pathogenic mechanisms causing the injury. The pathogenic mechanisms for medium-sized-vessel vasculitis are most effective at causing injury in arteries and are not effective at causing injury in smaller vessels. The predilection of medium-sized-vessel vasculitis for bifurcations may relate to the increased expression of adhesion molecules and increased numbers of intimal macrophages at these sites. The preferential involvement of small vessels by small-vessel vasculitis may relate to the requirement for close apposition between leukocytes and endothelial cells for the pathogenic mechanisms to be operational. The pathology of the necrotizing vasculitis of Kawasaki disease is most consistent with a primary role for monocytes/macrophages and T lymphocytes in the acute injury. The pathology of the necrotizing vasculitis of polyarteritis nodosa and small-vessel vasculitis, including ANCA-vasculitis, is most consistent with a primary role for neutrophils and monocytes in the acute injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086262     DOI: 10.3949/ccjm.69.suppl_2.sii33

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  11 in total

1.  [Polyarteritis nodosa: differential diagnostics and therapy].

Authors:  J H Schirmer; K Holl-Ulrich; F Moosig
Journal:  Z Rheumatol       Date:  2014-12       Impact factor: 1.372

2.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Authors:  Hong Xiao; Adrian Schreiber; Peter Heeringa; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 3.  [New pathogenetic aspects in primary systemic vasculitides].

Authors:  P Lamprecht
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

Review 4.  Polyarteritis nodosa revisited.

Authors:  Inés Colmegna; José A Maldonado-Cocco
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

5.  [Update: polyarteritis nodosa].

Authors:  Jan H Schirmer; Frank Moosig
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

6.  Cardiovascular complications associated with chronic active Epstein-Barr virus infection.

Authors:  Jun Muneuchi; Shouichi Ohga; Masataka Ishimura; Kazuyuki Ikeda; Kenichiro Yamaguchi; Akihiko Nomura; Hidetoshi Takada; Yasunobu Abe; Toshiro Hara
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

7.  Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.

Authors:  Alzírton de Lira Freire; Manoel Barros Bertolo; Antônio José de Pinho; Adil Muhib Samara; Sandra Regina Muchinechi Fernandes
Journal:  Clin Rheumatol       Date:  2004-04-02       Impact factor: 2.980

8.  Clinical manifestations vary with different age spectrums in infants with Kawasaki disease.

Authors:  Hao-Chuan Liu; Chiao-Wei Lo; Betau Hwang; Pi-Chang Lee
Journal:  ScientificWorldJournal       Date:  2012-02-15

9.  Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis.

Authors:  Chie Miyabe; Yoshishige Miyabe; Jun Nagai; Noriko N Miura; Naohito Ohno; Jerold Chun; Ryoji Tsuboi; Hiroshi Ueda; Masayuki Miyasaka; Nobuyuki Miyasaka; Toshihiro Nanki
Journal:  Arthritis Res Ther       Date:  2019-08-20       Impact factor: 5.156

10.  Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Joon-Sung Lee
Journal:  Med Hypotheses       Date:  2007-03-06       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.